CONSULTING AGREEMENTConsulting Agreement • September 2nd, 2020 • Galectin Therapeutics Inc • Pharmaceutical preparations • Georgia
THIS CONSULTING AGREEMENT (this “Consulting Agreement”) is made and entered as of the 31st day of August, 2020 (the “Execution Date”), by and between Galectin Therapeutics Inc., a corporation incorporated under the laws of the State of Nevada (the “Company”), and Harold H. Shlevin, Ph.D. (“Shlevin”), an individual residing in the State of Florida.
EMPLOYMENT AGREEMENTEmployment Agreement • September 2nd, 2020 • Galectin Therapeutics Inc • Pharmaceutical preparations • Georgia
THIS EMPLOYMENT AGREEMENT (this “Agreement”) is made this 31st day of August, 2020 by and between Galectin Therapeutics Inc., a Nevada corporation (the “Company”), and Joel Lewis (“Executive”).
RETIREMENT AGREEMENTRetirement Agreement • September 2nd, 2020 • Galectin Therapeutics Inc • Pharmaceutical preparations • Georgia
This Retirement Agreement (the “Retirement Agreement”) is entered into as of August 31, 2020, by and between Harold H. Shlevin, Ph.D. ( “Executive”), an individual residing in the State of Florida, and Galectin Therapeutics, Inc. (the “Company”), a Nevada corporation, effective on the date of Executive’s signature below (the “Effective Date”).
DEFERRED STOCK UNIT AGREEMENT UNDER THE GALECTIN THERAPEUTICS INC. August 31, 2020Deferred Stock Unit Agreement • September 2nd, 2020 • Galectin Therapeutics Inc • Pharmaceutical preparations
Pursuant to the terms of the Galectin Therapeutics Inc. 2019 Omnibus Equity Compensation Plan (the “Plan”), Galectin Therapeutics Inc., a Nevada corporation (the “Company”) will issue the number of shares of the Company’s common stock equal to the number of Deferred Stock Units (“DSUs”) granted in accordance with the terms set forth in this agreement (the “Agreement”).
